Olodaterol
Olodaterol is a long-acting beta2-adrenergic agonist (LABA) bronchodilator used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, allowing for easier breathing. This medication is often combined with anticholinergic agents like tiotropium for enhanced bronchodilation.
Olodaterol is a long-acting bronchodilator used to manage symptoms of chronic obstructive pulmonary disease (COPD) by relaxing airway muscles and improving breathing.
Key facts at a glance
- ATC
- R03AC19
- RxNorm
- 1546059
- Generic
- Olodaterol
- Class
- atc-r03
- Brands
- Striverdi, Stiolto
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- spray
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Dosage and administration
- Usual dose
- 5 mcg once daily
- Maximum
- consult physician
- Frequency
- once daily
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- not indicated for pediatric use
- Maximum
- consult physician
- Frequency
- not applicable
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 5 mcg once daily
- Maximum
- consult physician
- Frequency
- once daily
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
Overdose information
Special Populations
11 groupspregnancy
first trimesteravoid if possible
avoid use during pregnancy unless benefits outweigh risks
regular fetal monitoring
Use with caution and monitor for adverse effects.
pregnancy
second trimesteruse lowest effective dose
use only if needed for COPD control
fetal growth monitoring
Use with caution and monitor for adverse effects.
pregnancy
third trimesteravoid if possible
discontinue before delivery if possible
fetal monitoring
Use with caution and monitor for adverse effects.
lactation
breastfeedinguse with caution
use only if clearly needed, consider infant exposure
monitor infant for respiratory symptoms
geriatric
elderly 65no adjustment needed
standard dosing appropriate
standard COPD monitoring
pediatric_age
adolescents 12 17not recommended
not approved for patients under 18 years
not applicable
Use of this medication in this population requires careful consideration of risks and benefits.
pediatric_age
children 6 11not recommended
not approved for patients under 18 years
not applicable
Use of this medication in this population requires careful consideration of risks and benefits.
renal_impairment
mild moderateno adjustment needed
standard dosing appropriate
standard renal function monitoring
renal_impairment
severeuse with caution
monitor closely
renal function monitoring
Use with caution and monitor for adverse effects.
hepatic_impairment
mild moderateno adjustment needed
standard dosing appropriate
standard liver function monitoring
hepatic_impairment
severeuse with caution
limited data, use with caution
liver function monitoring
Use with caution and monitor for adverse effects.
Statistics and clinical data
FDA approval year
FDA approval for Striverdi Respimat
Drug class
bronchodilator for COPD maintenance
Common uses
Long-term maintenance therapy for chronic obstructive pulmonary disease
Delivery method
Metered dose inhaler device
Olodaterol is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is not intended for acute bronchospasm relief or for use as a rescue inhaler during sudden breathing difficulties.
As a beta2-agonist, Olodaterol stimulates beta2-adrenergic receptors in the bronchial smooth muscle, causing relaxation and subsequent dilation of the airways. This reduces airway resistance and improves airflow, making it easier to breathe. When combined with anticholinergic agents like tiotropium in products like STIOLTO RESPIMAT, it provides dual-action bronchodilation through different mechanisms.
Olodaterol is typically administered via oral inhalation using a specialized inhaler device. Patients should not exceed the prescribed dose. It is not recommended as a first-line treatment for asthma and should be used with caution in patients with cardiovascular conditions, diabetes, or seizures. Common side effects may include upper respiratory tract infections, nasopharyngitis, and cough.
Contraindications
Conditions and patient states where this medication should be avoided or used with caution.
Do not use (1)
Known allergy to this medication or its components
Use caution (1)
Consult healthcare provider for benefits vs risks assessment
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy